National Bank of Canada’s CureVac CVAC Stock Holding History

National Bank of Canada’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,160	Closed	-$38.6K	–	2939
2025 Q3	$38.6K	Sell	7,160 -251,800	-97%	-$1.36M	﹤0.01%	2006
2025 Q2	$1.41M	Buy	258,960 +258,900	+431,500%	+$1.03M	﹤0.01%	1214
2025 Q1	$167	Sell	60 -6,000	-99%	-$20.9K	﹤0.01%	2698
2024 Q4	$20.7K	Buy	6,060 +5,343	+745%	+$15.4K	﹤0.01%	2173
2024 Q3	$2.11K	Buy	717 +657	+1,095%	+$2.16K	﹤0.01%	2348
2024 Q2	$200	Hold	60	–	–	﹤0.01%	2605
2024 Q1	$175	Hold	60	–	–	﹤0.01%	2644
2023 Q4	$251	Hold	60	–	–	﹤0.01%	2628
2023 Q3	$384	Hold	60	–	–	﹤0.01%	2666
2023 Q2	$625	Hold	60	–	–	﹤0.01%	2598
2023 Q1	$417	Hold	60	–	–	﹤0.01%	2600
2022 Q4	$359	Hold	60	–	–	﹤0.01%	2666
2022 Q3	$0	Sell	60 -60	-50%	-$700	﹤0.01%	2725
2022 Q2	$2K	Hold	120	–	–	﹤0.01%	2587
2022 Q1	$2K	Hold	120	–	–	﹤0.01%	2692
2021 Q4	$4K	Buy	+120	New	+$4.83K	﹤0.01%	2568

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

National Bank of Canada's CVAC Position: Q4 2025 in Review

National Bank of Canada sold out of CureVac (CVAC) in Q4 2025, closing a stake of 7,160 shares — an estimated $38.6K sold.

National Bank of Canada first reported a position in CVAC in Q4 2021 and held it in 16 quarters. The position peaked at $1.41M in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

National Bank of Canada reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
National Bank of Canada sold 7,160 CureVac shares in Q4 2025, an estimated $38.6K.
National Bank of Canada first reported a position in CureVac in Q4 2021 and held it in 16 quarters.
National Bank of Canada's CureVac position peaked at $1.41M in Q2 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.